Stridex Xl Face And Body Pads Liquid
NDC Package 10157-2114-1
Package Information
Stridex Xl Face And Body Pads (salicylic acid) liquids is clean the skin thoroughly before applying this productuse the pad to cover the entire affected area with a thin layer one to three times dailybecause excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other daydo not leave pad on skin for an extended period of timekeep away from eyes, lips and other mucous membranes. This formulation utilizes a liquid delivery system. Marketed by Blistex Inc, this product is identified by NDC 10157-2114 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 1425554 - Stridex 2 % Medicated Pad
- RxCUI: 1425554 - salicylic acid 20 MG/ML Medicated Pad [Stridex]
- RxCUI: 1425554 - Stridex 20 MG/ML Medicated Pad
- RxCUI: 797892 - salicylic acid 2 % Medicated Pad
- RxCUI: 797892 - salicylic acid 20 MG/ML Medicated Pad
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10157 - Blistex Inc
- 10157-2114 - Stridex Xl Face And Body Pads
- 10157-2114-1 - 1 JAR in 1 CARTON / 90 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR
- 10157-2114 - Stridex Xl Face And Body Pads
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10157-2114-1 identifies a specific commercial package of 1 jar in 1 carton / 90 applicator in 1 jar / 2 ml in 1 applicator of Stridex Xl Face And Body Pads, a human over the counter drug labeled by Blistex Inc. This liquid is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Blistex Inc on September 20, 2020. The current certification is valid through December 31, 2026.
How is this Blistex Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10157211401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.